Medicare Enrolled

Dr. Augusto Miravalle, MD

Neurology · Chicago, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1725 W HARRISON ST STE 309, Chicago, IL 60612
3129428011
In practice since 2009 (17 years)
NPI: 1629216627 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miravalle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miravalle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miravalle

Dr. Augusto Miravalle is a neurology specialist in Chicago, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Miravalle performed 6,967 Medicare services across 270 unique beneficiaries.

Between the years covered by Open Payments, Dr. Miravalle received a total of $1,103,127 from 76 pharmaceutical and/or device companies across 1821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miravalle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 9% volume in IL $1,103,127 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,967
Medicare services
Top 9% in IL for neurology
270
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~410 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
6,700 $5 $9
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $74 $206
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
60 $57 $148
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
24 $98 $1,000
New patient office visit, complex (60-74 min) 24 $126 $398
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $113 $294
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $100 $313
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,103,127
Total received (2018-2024)
Avg $157,590/year across 7 years
Top 0% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
1,821
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$944,323 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$138,027 (12.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,270 (1.2%)
Scientific / Research
Research funding and grants
$7,507 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$261,511
2023
$172,925
2022
$174,268
2021
$99,731
2020
$92,614
2019
$260,639
2018
$41,441

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$144,648
Amgen Inc.
$28,610
TG Therapeutics, Inc.
$27,862
Alexion Pharmaceuticals, Inc.
$17,325
Genentech USA, Inc.
$14,327
E.R. Squibb & Sons, L.L.C.
$9,163
GENZYME CORPORATION
$8,413
Celgene Corporation
$7,389
Novartis Pharmaceuticals Corporation
$3,624
Biogen, Inc.
$149
Top 3 companies account for 76.9% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$331,906
Genentech USA, Inc.
$174,200
Alexion Pharmaceuticals, Inc.
$94,694
Novartis Pharmaceuticals Corporation
$85,415
Biogen, Inc.
$81,149
E.R. Squibb & Sons, L.L.C.
$78,461
GENZYME CORPORATION
$68,164
Horizon Therapeutics plc
$51,977
Celgene Corporation
$47,358
Amgen Inc.
$29,391
TG Therapeutics, Inc.
$27,960
Janssen Global Services, LLC
$8,370
TG THERAPEUTICS, INC.
$4,626
Ares Trading SA
$3,405
Allergan, Inc.
$2,414
Merck KGaA
$1,760
Genentech, Inc.
$1,677
Mallinckrodt Enterprises LLC
$1,526
ABBVIE INC.
$1,194
Teva Pharmaceuticals USA, Inc.
$714
UCB, Inc.
$621
Mallinckrodt Hospital Products Inc.
$528
AbbVie Inc.
$487
Neurocrine Biosciences, Inc.
$429
Supernus Pharmaceuticals, Inc.
$345
Lundbeck LLC
$341
Sunovion Pharmaceuticals Inc.
$320
Biohaven Pharmaceutical Holding Company Ltd.
$306
PFIZER INC.
$296
Lilly USA, LLC
$269
Biohaven Pharmaceuticals, Inc.
$252
Mallinckrodt LLC
$200
Janssen Pharmaceuticals, Inc
$191
US WorldMeds, LLC
$172
SK Life Science, Inc.
$169
Acorda Therapeutics, Inc
$138
Medtronic USA, Inc.
$122
GRT US Holding, Inc.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
Neurelis, Inc.
$108
Allergan Inc.
$100
MDD US Operations, LLC
$91
Bausch Health US, LLC
$83
Amneal Pharmaceuticals LLC
$71
CSL Behring
$61
Grifols USA, LLC
$55
EISAI INC.
$52
Avanir Pharmaceuticals, Inc.
$52
JAZZ PHARMACEUTICALS INC.
$51
Abbott Laboratories
$45
MERZ NORTH AMERICA, INC.
$43
Eisai Inc.
$41
Adamas Pharmaceuticals, Inc.
$38
ACADIA Pharmaceuticals Inc
$34
Merz Pharmaceuticals, LLC
$27
Collegium Pharmaceutical, Inc.
$26
LivaNova USA, Inc.
$26
Merz North America, Inc.
$24
ASSERTIO THERAPEUTICS, Inc.
$23
Octapharma USA, Inc.
$23
BANNER LIFE SCIENCES, LLC
$22
Bioventus LLC
$22
Upsher-Smith Laboratories LLC
$22
Saol Therapeutics Inc.
$21
CATALYST PHARMACEUTICALS, INC.
$20
Greenwich Biosciences, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$18
Alnylam Pharmaceuticals Inc.
$17
Akcea Therapeutics, Inc.
$16
Retrophin, Inc.
$16
ARGENX US, INC.
$15
Boston Scientific Corporation
$15
Vertical Pharmaceuticals, LLC
$14
Scilex Pharmaceuticals Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
Exeltis, USA Inc.
$12
Top 3 companies account for 54.5% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · COPAXONE · DISEASE STATE · DUOPA · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evobrutinib · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · L300 Go System · LEMTRADA · LIORESAL · LYRICA · Lioresal (baclofen) · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · MYOBLOC · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · OSMOLEX ER · Ocrevus · Ongentys · Ozanimod · PANZYGA · POMPE - DISEASE · PRADAXA · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RYTARY · React · Rebif · Rituxan · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · WATCHMAN Access System · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZERIT · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in IL.

Looking for a neurology specialist in Chicago?
Compare neurologists in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
615
Per 100K population
11.9
County median income
$81,797
Nearest hospital
JESSE BROWN VA MEDICAL CENTER - VA CHICAGO HEALTHCARE SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Miravalle is a mixed practice specialist, with above-average Medicare volume (top 9% in IL), with speaking/promotional industry engagement in the top 0% of IL peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Miravalle experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Miravalle performed 6,700 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miravalle receive payments from pharmaceutical companies?
Yes. Dr. Miravalle received a total of $1,103,127 from 76 companies across 1,821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miravalle's costs compare to other neurologists in Chicago?
Dr. Miravalle's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miravalle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →